From: Proinflammatory cytokines regulate epidermal stem cells in wound epithelialization
Targeted cells or factors | Molecule or cell tested | Route of application | Subject | Therapeutic effect | Ref |
---|---|---|---|---|---|
Stem cells | Hair follicle stem cells | Direct application-hair skin graft | Patients | Less ulcer area, more granulation tissue formation and vascularization, and better innervation of the wound bed | |
Hair follicle stem cells | Intradermal injection | Rats | Less inflammation, more granulation tissue formation, and faster vascularization and epithelialization | [52] | |
Hair follicle stem cells | Local injection | Patients | Increased hair density and hair follicle number | ||
Mesenchymal stem cells | Injection/spray | Mice/patients | Less inflammatory cells, proinflammatory cytokines, and scar formation as well as faster wound closure | [55] | |
TNF-α | Anti-TNF-α neutralizing antibody | Topical application | Mice/patients | Less leukocyte recruitment, rebalance of M1/M2 macrophages, more matrix synthesis, and faster wound healing | |
IL-1 | Anti-IL-1β neutralizing antibody | Topical application | Cultured macrophages/mice | Lower proinflammatory macrophage phenotype and proinflammatory cytokines expression. Faster re-epithelialization and granulation tissue formation and more collagen deposition | [61] |
IL-1 receptor antagonist | Topical application | Mice | Less leukocyte and macrophage recruitment and faster wound healing | [62] | |
IL-17 | Anti-IL-17A antibody | Local injection | Mice | More pro-healing macrophages and better wound closure | [63] |